This site uses cookies, tags and tracking settings to store information that help give you the very best browsing experience. If you don't change your settings, we'll assume you're happy with this. More information Dismiss this warning

EGF mutant receptor vIII as a molecular target in cancer therapy.

in Endocrine-Related Cancer
Authors:
C T Kuan Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Search for other papers by C T Kuan in
Current site
Google Scholar
PubMed
Close
,
C J Wikstrand Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Search for other papers by C J Wikstrand in
Current site
Google Scholar
PubMed
Close
, and
D D Bigner Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Search for other papers by D D Bigner in
Current site
Google Scholar
PubMed
Close
Free access

Sign up for journal news

 

  • Collapse
  • Expand